GlassScriptPhysician profile
Caroline Wescott
NPI 1992138937
$2,170.28
in general payments reported to CMS, 2019-2025
19 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $530 · 2022: $477 · 2023: $412 · 2024: $517 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.15 | 2021-2024 | |
| Amgen INC. | $320.73 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $269.08 | 2022-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $171.78 | 2021-2023 | Proclaim |
| Si-Bone, INC. | $143.49 | 2021 | |
| Medtronic, INC. | $125.21 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Grt US Holding, INC. | $124.77 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.04 | 2022 | |
| Vertos Medical, INC. | $121.37 | 2023 | Mild Device Kit |
| Pfizer INC. | $101.63 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $100.87 | 2023-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.86 | 2023 | Relistor |
| Averitas Pharma INC. | $44.46 | 2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $36.28 | 2021 | |
| Spr Therapeutics, INC | $31.40 | 2023 | Sprint Pns System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $30.13 | 2023 | Evoke Scs |
| Convatec INC. | $19.17 | 2025 | |
| Bioventus LLC | $17.32 | 2021 | |
| Appliedvr INC | $14.54 | 2025 | Relievrx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Wescott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.